Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A list of radical ideas for transforming the NHS, including lifting safeguards blocking startups’ access to patient data, and nurses being incentivised to help speed trials, was privately drawn up by drug and healthcare companies in talks with senior No 10 advisers.
The proposals, which can be revealed after a freedom of information request, emerged in private roundtables convened by a taskforce appointed by Boris Johnson to generate ideas for cutting supposed red tape after Brexit.
But campaigners for transparency and patient confidentiality expressed concern that the suggestions, which included criticism of what was described as “false protectors of patient interests”, could lower standards and weaken patient protections if implemented.
The ideas emerged in a “pharma round table” attended by representatives of companies including GlaxoSmithKline, Johnson & Johnson, drug firm lobbyists and figures including Johnson’s chief health adviser, William Warr, and at another for digital health.
The proposals, which can be revealed after a freedom of information request, emerged in private roundtables convened by a taskforce appointed by Boris Johnson to generate ideas for cutting supposed red tape after Brexit.
But campaigners for transparency and patient confidentiality expressed concern that the suggestions, which included criticism of what was described as “false protectors of patient interests”, could lower standards and weaken patient protections if implemented.
The ideas emerged in a “pharma round table” attended by representatives of companies including GlaxoSmithKline, Johnson & Johnson, drug firm lobbyists and figures including Johnson’s chief health adviser, William Warr, and at another for digital health.
Radical plans to transform NHS drawn up at drug firms and No 10 roundtable
Exclusive: ideas include reducing trial safeguards and allowing startups to harvest patient data
www.theguardian.com